Nohla Therapeutics
Nohla Therapeutics is a Seattle-based therapeutics company that Ben Bergo previously co-founded.
Facts
- HQ
- Seattle
- Sectors
- Biotech, Therapeutics
- Stage
- Series B
- Members see funding amounts. .
Is this your organization? Claim it
Seattle’s Deverra Therapeutics Raises $2.4M to Develop Cellular Immunotherapies with Fred Hutch License
Seattle biotech startup Deverra Therapeutics, founded by oncologist Colleen Delaney, is raising $2.4 million through debt and warrants to advance its cellular immunotherapy platform licensed from Fred Hutch. The company recently secured $3.5 million from the Andy Hill CARE Fund and licensed an immuno-oncology platform from Coeptis Therapeutics for $570,000 plus shares.
Visus Therapeutics raises $20M to advance BRIMOCHOL presbyopia eye drop after $36M round six months earlier
Seattle startup Visus Therapeutics raised $20 million to develop BRIMOCHOL, a once-daily eye drop intended to treat presbyopia, following a $36 million raise six months earlier.
Visus Therapeutics raises $36M Series A from Johnson & Johnson Innovation, RTW Investments and others to advance BRIMOCHOL presbyopia eye drop
Visus Therapeutics, a Seattle startup developing BRIMOCHOL, a once-daily presbyopia-correcting eye drop, raised $36 million in a Series A led in part by Johnson & Johnson Innovation alongside RTW Investments, Wille AG and existing investors.
See all 9 stories, episodes and videos about Nohla Therapeutics.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events